8,9-Dehydroestrone Explained

Iupac Name:(13S,14S)-3-Hydroxy-13-methyl-7,11,12,14,15,16-hexahydro-6H-cyclopenta[''a'']phenanthren-17-one
Width:225px
Routes Of Administration:By mouth
Class:Estrogen
Cas Number:474-87-3
Pubchem:6451472
Chemspiderid:4953937
Unii:7C1N8RKG9F
Synonyms:Δ8-Estrone; Estra-1,3,5(10),8-tetraen-3-ol-17-one
C:18
H:20
O:2
Smiles:C[C@]12CCC3=C([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)O
Stdinchi:1S/C18H20O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,16,19H,2,4,6-9H2,1H3/t16-,18-/m0/s1
Stdinchikey:OUGSRCWSHMWPQE-WMZOPIPTSA-N

8,9-Dehydroestrone, or Δ8-estrone, also known as estra-1,3,5(10),8-tetraen-3-ol-17-one, is a naturally occurring estrogen found in horses which is closely related to equilin, equilenin, and estrone, and, as the 3-sulfate ester sodium salt, is a minor constituent (3.5%) of conjugated estrogens (Premarin).[1] [2] [3] [4] It produces 8,9-dehydro-17β-estradiol as an important active metabolite, analogously to conversion of estrone or estrone sulfate into estradiol.[5] The compound was first described in 1997.[6] In addition to 8,9-dehydroestrone and 8,9-dehydro-17β-estradiol, 8,9-dehydro-17α-estradiol is likely also to be present in conjugated estrogens, but has not been identified at this time.

See also

Notes and References

  1. Book: Fritz MA, Speroff L . Postmenopausal Hormone Therapy . Clinical Gynecologic Endocrinology and Infertility. https://books.google.com/books?id=KZLubBxJEwEC&pg=PA751 . 28 March 2012. Lippincott Williams & Wilkins. 978-1-4511-4847-3. 751–.
  2. Bhavnani BR . Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism . Proceedings of the Society for Experimental Biology and Medicine . 217 . 1 . 6–16 . January 1998 . 9421201 . 10.3181/00379727-217-44199 . 45177839 .
  3. Bhavnani BR, Cecutti A, Gerulath A . Pharmacokinetics and pharmacodynamics of a novel estrogen delta8-estrone in postmenopausal women and men . The Journal of Steroid Biochemistry and Molecular Biology . 67 . 2 . 119–131 . October 1998 . 9877212 . 10.1016/s0960-0760(98)00082-x . 54352249 .
  4. Baracat E, Haidar M, Lopez FJ, Pickar J, Dey M, Negro-Vilar A . Estrogen activity and novel tissue selectivity of delta8,9-dehydroestrone sulfate in postmenopausal women . The Journal of Clinical Endocrinology and Metabolism . 84 . 6 . 2020–2027 . June 1999 . 10372704 . 10.1210/jcem.84.6.5800 . free .
  5. Kuhl H . Pharmacology of estrogens and progestogens: influence of different routes of administration . Climacteric . 8 . Suppl 1 . 3–63 . August 2005 . 16112947 . 10.1080/13697130500148875 . 24616324 .
  6. Bhavnani BR, Cecutti A, Dey MS . Effects in postmenopausal women of delta-8-estrone sulfate: A novel estrogen component of Premarin. . Journal Society Gynecologic Investigation . 1997 . 4 . 1 (Suppl . 392 .